ReviewFrontiers in psychology2026
Research progress on the characteristic features of non-suicidal self-injury addiction, neuroimaging correlates, and evidence-based interventions in adolescents.
Review in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Cross-Matrix Peripheral Transcriptional Signature in Suicide Attempt:International journal of molecular sciences · 2026Article
- Acceptance-Based and ACT-Informed Interventions for Non-Suicidal Self-Injury in Adolescents: A Systematic Review and Exploratory Meta-Analysis.Children (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-suicidal self-injury (NSSI) represents a significant public health concern, particularly among adolescents. Recent conceptualizations posit that a severe, repetitive form of NSSI may be understood through an addiction framework, characterized by craving, loss of control, and continued use despite harm. However, an integrative model linking its behavioral phenotype, neurobiological underpinnings, and evidence-based treatment remains to be fully articulated. Methods: This narrative review synthesizes contemporary literature across psychological, neurobiological, and clinical domains to propose an integrative model of NSSI with addictive features. Results: The review establishes three key pillars of evidence. First, behaviorally, repetitive NSSI exhibits core addiction-like features driven by potent negative reinforcement. Intriguingly, this occurs alongside intact or even enhanced reactive inhibitory control, suggesting a specific dysregulation in reward-based decision-making rather than a global impulse deficit. Second, neurobiologically, this phenotype is supported by convergent findings of hypothalamic-pituitary-adrenal (HPA) axis dysregulation, a reward system biased towards distress relief, and dysfunctional fronto-limbic circuitry marked by limbic hyperreactivity and impaired prefrontal regulation. Third, therapeutically, Dialectical Behavior Therapy (DBT) emerges as the most effective intervention, with emerging evidence indicating it promotes symptom reduction through the neuroplastic normalization of this same fronto-limbic circuitry. The development of this addictive cycle is moderated by a transaction between risk factors (e.g., childhood adversity, peer victimization) and protective factors (e.g., resilience, self-efficacy). Conclusion: This synthesis supports the heuristic value of an addiction model for severe NSSI, providing a coherent framework that bridges behavior, brain, and treatment. Future translational research should focus on identifying biomarkers for the addictive subtype, developing circuit-targeted interventions, and implementing staged, multi-systemic prevention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.